SCHEMBL23115271

SCHEMBL23115271

CC1NC(C(=O)O)C(C)(C)S1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.30
CTDSP1 Q9GZU7 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28875199 0.78
SCHEMBL5870085 0.78 ARG1 (0.31)
SCHEMBL8701041 0.77
SCHEMBL13435199 0.75
SCHEMBL5498766 0.75
SCHEMBL3485597 0.74
SCHEMBL7552953 0.74 MEN1 (0.30)
SCHEMBL11391091 0.74 USP2 (0.31)
SCHEMBL24446257 0.70
SCHEMBL18196483 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11717554-B2 Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s) MAX R&D LLC (US) 2023-08-08 US disclosed
US-20210085746-A1 METHOD FOR PREVENTING OR TREATING HANGOVER SYMPTOM(S) ASSOCIATED WITH CONSUMPTION OF ALCOHOLIC BEVERAGE(S) NAGASAWA HERBERT (US) 2021-03-25 US disclosed